Key Points
- Osage University Gp Iii, LLC bought 533,333 Mobia Medical shares at $15.00 each, spending nearly $8.0 million in a disclosed insider transaction.
- The purchase increased Osage’s stake by 36.2%, bringing its direct ownership to 2,006,716 shares valued at about $30.1 million.
- Other insiders also bought stock, including director William T. Harrington and several additional directors, signaling broad insider confidence in the company.
Mobia Medical, Inc. (NASDAQ:MOBI - Get Free Report) major shareholder Osage University Gp Iii, Llc bought 533,333 shares of the firm's stock in a transaction on Monday, May 11th. The shares were bought at an average cost of $15.00 per share, with a total value of $7,999,995.00. Following the transaction, the insider directly owned 2,006,716 shares of the company's stock, valued at approximately $30,100,740. This trade represents a 36.20% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.
Mobia Medical Price Performance
Shares of Mobia Medical stock opened at $12.10 on Wednesday. The company has a market cap of $341.58 million, a price-to-earnings ratio of 67.22 and a beta of 2.84. Mobia Medical, Inc. has a 12-month low of $10.19 and a 12-month high of $14.00.
Key Mobia Medical News
Here are the key news stories impacting Mobia Medical this week:
- Positive Sentiment: Major shareholder Osage University Gp Iii, LLC bought 533,333 shares at $15.00 each, a nearly $8.0 million investment that lifted its position by 36.2%. SEC filing
- Positive Sentiment: Director William T. Harrington also purchased 533,333 shares at $15.00, matching the large insider commitment and reinforcing the bullish signal. SEC filing
- Positive Sentiment: Other directors and insiders added to positions as well, including Cynthia L. Lucchese (125,000 shares), Casey M. Tansey (66,666 shares), Dana G. Jr. Mead (7,000 shares), and Chase Leavitt (3,000 shares), suggesting broad insider support. Article on CEO outlook
- Neutral Sentiment: The company’s CEO is highlighting a large potential market for stroke rehabilitation, which supports the long-term growth narrative but does not yet include new financial results or guidance. Article title
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
